Editorial: early post-induction anti-TNF drug monitoring can predict long-term therapeutic outcomes in inflammatory bowel disease

被引：0
|
作者：
Papamichael, K. [1 ]
Cheifetz, A. S. [1 ]
机构：
[1] Harvard Med Sch, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Boston, MA 02115 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 47卷 / 03期
关键词：
ULCERATIVE-COLITIS; CROHNS-DISEASE; INFLIXIMAB;
D O I：
10.1111/apt.14461
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [11] Inflammatory Bowel Disease: New Therapeutic Options in the Post Anti-TNFα Era
    Jimenez-Perez, Miguel
    Olmedo-Martin, Raul V.
    Amo-Trillo, Victor M.
    Gonzalez-Grande, Rocio
    CURRENT DRUG METABOLISM, 2017, 18 (07) : 666 - 679
  • [12] EFFECT OF A PRACTICE-WIDE ANTI-TNF THERAPEUTIC DRUG MONITORING PROGRAM ON OUTCOMES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Lyles, John L.
    Mulgund, Aditi A.
    Bauman, Laura E.
    Su, Weizhe
    Fei, Lin
    Chona, Deepika
    Sharma, Puneet
    Etter, Renee
    Hellmann, Jennifer
    Denson, Lee A.
    Minar, Phillip P.
    Dykes, Dana M.
    Rosen, Michael J.
    GASTROENTEROLOGY, 2019, 156 (06) : S60 - S60
  • [13] The Long-Term Influence of Anti-TNF Agents on Hemoglobin Levels in Patients With Inflammatory Bowel Disease
    Koutroubakis, Ioannis E.
    Rivers, Claudia Ramos
    Regueiro, Miguel
    Koutroumpakis, Efstratios
    Click, Benjamin H.
    Schwartz, Marc
    Swoger, Jason M.
    Baidoo, Leonard
    Hashash, Jana G.
    Barrie, Arthur
    Dunn, Michael A.
    Binion, David G.
    GASTROENTEROLOGY, 2015, 148 (04) : S463 - S463
  • [14] Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
    Charabaty, Aline
    CROHNS & COLITIS 360, 2020, 2 (01)
  • [15] Utility of therapeutic anti-TNF drug monitoring in hospitals with different degree of experience in the treatment of inflammatory bowel disease
    Vila, M.
    Bahi, A.
    Miquel, J. O.
    Busquets, D.
    Salo, J.
    Aldeguer, X.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S90 - S90
  • [16] Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
    Marquez-Megias, Silvia
    Nalda-Molina, Ricardo
    Sanz-Valero, Javier
    Mas-Serrano, Patricio
    Diaz-Gonzalez, Marcos
    Candela-Boix, Maria Remedios
    Ramon-Lopez, Amelia
    PHARMACEUTICS, 2022, 14 (05)
  • [17] Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease
    Lyles, John L.
    Mulgund, Aditi A.
    Bauman, Laura E.
    Su, Weizhe
    Fei, Lin
    Chona, Deepika L.
    Sharma, Puneet
    Etter, Renee K.
    Hellmann, Jennifer
    Denson, Lee A.
    Minar, Phillip
    Dykes, Dana M.
    Rosen, Michael J.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (04) : 482 - 492
  • [18] Post-induction proactive anti-tumor necrosis factor therapeutic drug monitoring versus reactive drug monitoring in patients with inflammatory bowel disease to prevent loss of response and improve clinical outcomes
    Janjua, M.
    Picardo, S.
    So, K.
    Murray, R.
    Venugopal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 129 - 129
  • [19] Long-Term Outcomes of Proactive Therapeutic Drug Monitoring of Adalimumab and Standard of Care in Patients With Inflammatory Bowel Disease
    Dai, Cong
    Jiang, Min
    Yu, Ji-hong
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (08): : 1092 - 1093
  • [20] Long-term clinical outcomes after the discontinuation of anti-TNF agents in patients with inflammatory bowel disease: a meta-analysis
    Dai, Cong
    Wang, Yi-Nuo
    Tian, Wen-Ning
    Huang, Yu-Hong
    Jiang, Min
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (10) : 559 - 566
12345